Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
-INDIGO is the largest clinical trial conducted in patients living with IgG4-RD- -Topline INDIGO results expected by the end of 2025- WALTHAM, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Zenas...
-
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the...
-
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development...
-
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development...
-
WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based...
-
Financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital with significant participation from Enavate Sciences, Longitude Capital, and other new and existing investors Proceeds to...
-
วอลแทม รัฐแมสซาชูเซตส์ วันที่, March 07, 2024 (GLOBE NEWSWIRE) -- ในวันนี้ Zenas...
-
WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, sebuah syarikat biofarmaseutikal global yang komited untuk menjadi peneraju dalam pembangunan dan pengkomersilan terapi terarah...
-
マサチューセッツ州ウォルサム発, March 07, 2024 (GLOBE NEWSWIRE) --...
-
沃尔瑟姆，马萨诸塞州, March 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma 是一家全球生物制药公司，致力于成为炎症与免疫定向疗法开发和商业化的领导者，今日宣布任命 Patricia Allen 为董事会成员，同时她还将担任审计委员会主席。加入 Zenas 董事会时，Allen...